Crain's Chicago Business12h
Veradigm fails to find a buyer, moves to operational review
The health tech company formerly known as Allscripts, still reeling from failing to fix its financial reports, will have to ...
23andMe announces exploration of strategic alternatives
The Special Committee of the board of 23andMe Holding Co. announced that it has undertaken a process to explore strategic alternatives, including, among other alternatives, a poss ...
Sage rejects Biogen’s buyout offer, but says it's open to deals
Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...
23andMe says it's exploring alternatives, including a sale
Genetic testing firm 23andMe (NASDAQ:ME) said it formed a special board committee to review strategic alternatives. The special committee will look at options including a sale, business combination, ...
Zacks.com on MSN11d
NGVT to Evaluate Strategic Alternatives for Industrial Specialties
Ingevity Corporation NGVT recently announced plans to explore strategic alternatives for its Performance Chemicals Industrial ...
FiercePharma4d
No deal: Sage rejects Biogen's buyout offer, scouts for strategic alternatives
After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on ...
WILLOW ANNOUNCES INITIATION OF STRATEGIC REVIEW PROCESS
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on ...